Explore the details of the Teva Branded Pharmaceutical Products R&D Llc V. Armstrong Pharmaceuticals, Inc. case under case number 1:24-cv-00869 involving a cause of action for Patent Infringement. Review key information about the parties involved, the patents in question, and the docket entries.

Case Details

Case Number
1:24-cv-00869
Filing Date
Jul 25, 2024
Cause of Action
Patent Infringement
Status
-
Nature of Suit
Patent

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
Armstrong Pharmaceuticals, Inc. -
Teva Pharmaceuticals USA, Inc. -
Norton (Waterford) Ltd. -
Amphastar Pharmaceuticals, Inc. -

Patents Involved in the Case

Patents not found - set an alert to get notified when patents are added.

Docket Entries

The Docket Entries section provides a chronological list of all significant filings and court actions in this case.

DateDocket EntryType

Set alerts for critical docket entry

Oct 17, 2024Pro Hac Vice Attorney Matthew A. Lembo for Amphastar Pharmaceuticals, Inc.,Matthew A. Lembo for Armstrong Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (scs)PACER Document
Oct 31, 2024SO ORDERED re 15 STIPULATED MOTION TO EXTEND TIME to File Proposed Scheduling Order to December 4, 2024. ORDERED by Judge Maryellen Noreika on 10/31/2024. (dlw)PACER Document
Dec 4, 2024PROPOSED ORDER // Scheduling Order by Teva Branded Pharmaceutical Products R&D, Inc., Norton (Waterford) Ltd., Teva Pharmaceuticals USA, Inc. (Attachments: # 1 Cover Letter)(Hoeschen, Nathan) Modified on 12/4/2024 (dlw). (Main Document 17 replaced on 12/17/2024) (dlw). (Entered: 12/04/2024)PACER Document
Dec 16, 2024MOTION for Pro Hac Vice Appearance of Attorney Daryl L. Wiesen, Louis L. Lobel, Thomas V. McTigue IV and Annaka Nava - filed by Teva Branded Pharmaceutical Products R&D, Inc., Norton (Waterford) Ltd., Teva Pharmaceuticals USA, Inc.. (Hoeschen, Nathan) (Entered: 12/16/2024)PACER Document
Dec 18, 2024SCHEDULING ORDER: Joinder of Parties due by 2/3/2025. Amended Pleadings due by 2/3/2025. Fact Discovery completed by 9/12/2025. Opening Expert Reports due by 4/24/2026. Rebuttal Expert Reports due by 6/19/2026. Reply Expert Reports due by 7/17/2026. Expert Discovery due by 9/10/2026. Dispositive Motions due by 9/25/2026. Answering Brief due 10/29/2026. Reply Brief due 11/12/2026. Claim Construction Opening Brief served by 10/24/2025. Claim Construction Answering Brief served by 11/21/2025. Claim Construction Reply Brief served by 12/23/2025. Claim Construction Surreply Brief served by 1/9/2026. Joint Claim Construction Brief filed by 1/20/2026. A Markman Hearing is set for 2/20/2026 at 10:00 AM in Courtroom 4A before Judge Maryellen Noreika. A Pretrial Conference is set for 3/1/2027 at 04:30 PM in Courtroom 4A before Judge Maryellen Noreika. A 5-day Jury Trial is set for 3/8/2027 at 09:30 AM in Courtroom 4A before Judge Maryellen Noreika. Signed by Judge Maryellen Noreika on 12/18/2024. (dlw) (Entered: 12/18/2024)PACER Document
Jan 8, 2025NOTICE OF SERVICE of Plaintiffs' Identification of Accused Products, Asserted Patents and File Histories, and Damages Model filed by Teva Branded Pharmaceutical Products R&D, Inc., Norton (Waterford) Ltd., Teva Pharmaceuticals USA, Inc..(Keller, Karen) (Entered: 01/08/2025)PACER Document
Jan 10, 2025STIPULATION TO EXTEND TIME to Submit an Application to the Court for a Protective Order and to Exchange Rule 26(a) Initial Disclosures to February 6, 2025 - filed by Teva Branded Pharmaceutical Products R&D, Inc., Norton (Waterford) Ltd., Teva Pharmaceuticals USA, Inc.. (Hoeschen, Nathan) (Entered: 01/10/2025)PACER Document
Feb 10, 2025Consent Order of Dismissal by Teva Branded Pharmaceutical Products R&D, Inc., Norton (Waterford) Ltd., Teva Pharmaceuticals USA, Inc. (Keller, Karen) Modified on 2/11/2025 (dlw). (Entered: 02/10/2025)PACER Document
Feb 10, 2025Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Teva Pharmaceutical Industries Ltd. for Norton (Waterford) Ltd., Teva Branded Pharmaceutical Products R&D, Inc., Teva Pharmaceuticals USA, Inc. filed by Teva Branded Pharmaceutical Products R&D, Inc., Norton (Waterford) Ltd., Teva Pharmaceuticals USA, Inc.. (Keller, Karen) (Entered: 02/10/2025)PACER Document
Feb 10, 2025NOTICE of Change of Name and Request to Update Party's Name on Docket by Teva Branded Pharmaceutical Products R&D, Inc., Norton (Waterford) Ltd., Teva Pharmaceuticals USA, Inc. (Keller, Karen) (Entered: 02/10/2025)PACER Document
Feb 11, 2025SO ORDERED re 25 CONSENT ORDER OF DISMISSAL ***Civil Case Terminated. Signed by Judge Maryellen Noreika on 2/11/2025. (dlw) (Entered: 02/11/2025)PACER Document
Feb 11, 2025Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s). (Attachments: # 1 Dismissal)(mdb) (Entered: 02/11/2025)PACER Document
Dec 16, 2024Pro Hac Vice Fee - Credit Card Payment received for Daryl L. Wiesen, Louis L. Lobel, Thomas V. McTigue IV, and Annaka Nava. ( re 18 MOTION for Pro Hac Vice Appearance of Attorney Daryl L. Wiesen, Louis L. Lobel, Thomas V. McTigue IV and Annaka Nava )( Payment of $ 200, receipt number ADEDC-4571246).(Hoeschen, Nathan) (Entered: 12/16/2024)PACER Document
Dec 16, 2024SO ORDERED re 18 MOTION for Pro Hac Vice Appearance of Attorney Daryl L. Wiesen, Louis L. Lobel, Thomas V. McTigue IV and Annaka Nava filed by Norton (Waterford) Ltd., Teva Branded Pharmaceutical Products R&D, Inc., Teva Pharmaceuticals USA, Inc. ORDERED by Judge Maryellen Noreika on 12/16/2024. (dlw)PACER Document
Dec 16, 2024Pro Hac Vice Attorney Annaka Nava,Louis L. Lobel,Thomas V. McTigue, IV,Daryl L. Wiesen for Norton (Waterford) Ltd., Teva Branded Pharmaceutical Products R&D, Inc., Teva Pharmaceuticals USA, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (scs)PACER Document
Jan 10, 2025SO ORDERED re 22 STIPULATION TO EXTEND TIME to Submit an Application to the Court for a Protective Order and to Exchange Rule 26(a) Initial Disclosures to February 6, 2025. ORDERED by Judge Maryellen Noreika on 1/10/2025. (dlw)PACER Document